Novel Combination Therapy for Osteoporosis in Men

NCT03994172 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

FED

Sponsor class

Conditions

Male Osteoporosis

Interventions

DRUG: Teriparatide or human parathyroid hormone (PTH) 1-34
DRUG: Cinacalcet
DRUG: placebo tablet
DIETARY_SUPPLEMENT: Calcium citrate tablet
DIETARY_SUPPLEMENT: Vitamin D3

Sponsor

VA Office of Research and Development

Collaborators

[object Object]